$7.03
At close: May 6 EDT
$6.60
-0.43-6.12%
Pre-Market: 4:13 AM EDT
Comments
Loading...
Bioventus Stock Guidance | NASDAQ:BVS | Benzinga
Bioventus issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/11/2025 | BVS | Bioventus | FY | 2025 | $0.64 | $0.68 | $0.55 | $560.00M | $570.00M | $554.78M | Get Alert |
| 11/05/2024 | BVS | Bioventus | FY | 2024 | $0.40 | $0.42 | $0.39 | $562.00M | $567.00M | $561.77M | Get Alert |
| 08/06/2024 | BVS | Bioventus | FY | 2024 | $0.36 | $0.42 | $0.28 | $557.00M | $567.00M | $542.77M | Get Alert |
| 05/07/2024 | BVS | Bioventus | FY | 2024 | $0.25 | $0.33 | $0.16 | $535.00M | $550.00M | $528.03M | Get Alert |
| 03/12/2024 | BVS | Bioventus | FY | 2024 | $0.12 | $0.20 | $0.33 | $520.00M | $535.00M | $517.82M | Get Alert |
| 11/07/2023 | BVS | Bioventus | FY | 2023 | -$0.12 | -$0.09 | -$0.19 | $498.00M | $505.00M | $499.79M | Get Alert |
| 08/08/2023 | BVS | Bioventus | FY | 2023 | -$0.24 | -$0.20 | -$0.22 | $490.00M | $505.00M | $493.14M | Get Alert |
| 11/21/2022 | BVS | Bioventus | FY | 2022 | $0.20 | $0.25 | $0.26 | $517.00M | $522.00M | $530.25M | Get Alert |
| 11/08/2022 | BVS | Bioventus | FY | 2022 | $0.20 | $0.25 | $0.51 | $527.00M | $532.00M | $553.86M | Get Alert |
| 08/11/2022 | BVS | Bioventus | FY | 2022 | $0.47 | $0.57 | $0.65 | $547.50M | $562.50M | $552.13M | Get Alert |
| 05/10/2022 | BVS | Bioventus | FY | 2022 | — | — | — | $545.00M | $565.00M | $553.75M | Get Alert |
| 05/03/2022 | BVS | Bioventus | FY | 2022 | — | — | — | $545.00M | $565.00M | $553.75M | Get Alert |
| 04/26/2022 | BVS | Bioventus | Q1 | 2022 | — | — | — | $116.50M | $118.50M | $117.76M | Get Alert |
| 03/10/2022 | BVS | Bioventus | FY | 2022 | — | — | — | $545.00M | $565.00M | $558.52M | Get Alert |
| 01/11/2022 | BVS | Bioventus | Q4 | 2021 | — | — | — | $128.50M | $131.50M | $124.56M | Get Alert |
| 01/11/2022 | BVS | Bioventus | FY | 2021 | — | — | — | $429.00M | $432.00M | $429.33M | Get Alert |
| 11/09/2021 | BVS | Bioventus | FY | 2021 | — | — | — | $425.00M | $430.00M | $410.24M | Get Alert |
| 08/10/2021 | BVS | Bioventus | FY | 2021 | — | — | — | $405.00M | $415.00M | $400.94M | Get Alert |
| 07/29/2021 | BVS | Bioventus | Q2 | 2021 | — | — | — | $108.00M | $110.00M | $102.62M | Get Alert |
| 07/29/2021 | BVS | Bioventus | FY | 2021 | — | — | — | $405.00M | $415.00M | $400.94M | Get Alert |
| 05/12/2021 | BVS | Bioventus | FY | 2021 | — | — | — | $394.00M | $406.00M | $381.54M | Get Alert |
| 03/25/2021 | BVS | Bioventus | FY | 2021 | — | — | — | $360.00M | $372.00M | $364.48M | Get Alert |
FAQ
What is the most recent guidance for Bioventus (BVS)?
The most recent guidance for Bioventus (BVS) was reported on March 11, 2025 for the full year 2025. The company provided earnings per share guidance in the range of $0.64 to $0.68, compared to the estimated EPS of $0.55. Additionally, Bioventus forecasted revenue between $0.56B and $0.57B for the quarter.
Browse guidance and forecast on all stocks.
